Answers are grounded in this paper and cite their sources.
Retrospective study shows high survival rates in adolescents and young adults with leukaemia, suggesting need for consistent care pathways.
Adolescents and young adults (AYAs) with leukaemia represent a unique population but face fragmented care between paediatric and adult systems. A retrospective study of AYA patients (≥14 years old) with leukaemia treated at Shanghai Children’s Medical Center between September 2023 and March 2025 found acute lymphoblastic leukaemia (ALL) was predominant (152/189). AYA ALL patients showed a higher prevalence of high-risk subtypes like T-ALL and BCR::ABL1 , while favourable ETV6::RUNX1 was rare. Paediatric protocols achieved a 5-year event-free survival of 75.2% and overall survival of 89.6%, comparable to young children. These findings show that paediatric-based therapy for AYA ALL can be effective, although prospective comparative studies are still needed.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: